Distinct regional age effects on [11C]AZ10419369 binding to 5-HT1B receptors in the human brain

NeuroImage

Volumn 103, Issue , 2014, Pages 303-308

  Nord, Magdalena ^a   Cselenyi, Zsolt ^a,b   Forsberg, Anton ^a   Rosenqvist, Göran ^a   Tiger, Mikael ^a   Lundberg, Johan ^a   Varrone, Andrea ^a   Farde, Lars ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5 HT1B; Aging; PET; 11C AZ10419369

Indexed keywords

AZ 10419369 C 11; RADIOLIGAND; SEROTONIN 1B RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BINDING AFFINITY; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HUMAN; HUMAN EXPERIMENT; MALE; NEOCORTEX; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PUTAMEN; RADIOACTIVITY; RECEPTOR BINDING; YOUNG ADULT;

EID: 84908599692     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2014.09.040     Document Type: Article

References (46)

1. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res. 1993, 620:163-166.
2. Bergstrom M., Boethius J., Eriksson L., Greitz T., Ribbe T., Widen L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J. Comput. Assist. Tomogr. 1981, 5:136-141.
3. Blay S.L., Marinho V. Anxiety disorders in old age. Curr. Opin. Psychiatry 2012, 25:462-467.
4. Bonaventure P., Schotte A., Cras P., Leysen J.E. Autoradiographic mapping of 5-HT1B- and 5-HT1D receptors in human brain using [3H]alniditan, a new radioligand. Receptors Channels 1997, 5:225-230.
5. Bucht G., Adolfsson R., Gottfries C.G., Roos B.E., Winblad B. Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation. J. Neural Transm. 1981, 51:185-203.
6. Costes N., Merlet I., Ostrowsky K., Faillenot I., Lavenne F., Zimmer L., et al. A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. J. Nucl. Med. 2005, 46:1980-1989.
7. Ding Y.S., Singhal T., Planeta-Wilson B., Gallezot J.D., Nabulsi N., Labaree D., et al. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S, S)-[(11)C]O-methylreboxetine and HRRT. Synapse 2010, 64:30-38.
8. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989, 262:2551-2556.
9. Fidalgo S., Ivanov D.K., Wood S.H. Serotonin: from top to bottom. Biogerontology 2013, 14:21-45.
10. Filip M., Bader M. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol. Rep. 2009, 61:761-777.
11. Finnema S.J., Varrone A., Hwang T.J., Gulyas B., Pierson M.E., Halldin C., et al. Fenfluramine-induced serotonin release decreases [(11)C]AZ10419369 binding to 5-HT(1B)-receptors in the primate brain. Synapse 2010, 64:573-577.
12. Finnema S.J., Varrone A., Hwang T.J., Halldin C., Farde L. Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach. J. Cereb. Blood Flow Metab. 2012, 32:685-695.
13. Fritsch T., Smyth K.A., Wallendal M.S., Hyde T., Leo G., Geldmacher D.S. Parkinson disease: research update and clinical management. South. Med. J. 2012, 105:650-656.
14. Gallezot J.D., Nabulsi N., Neumeister A., Planeta-Wilson B., Williams W.A., Singhal T., et al. Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans. J. Cereb. Blood Flow Metab. 2010, 30:196-210.
15. Garcia-Alloza M., Hirst W.D., Chen C.P., Lasheras B., Francis P.T., Ramirez M.J. Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease. Neuropsychopharmacology 2004, 29:410-416.
16. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
17. Jucaite A., Forssberg H., Karlsson P., Halldin C., Farde L. Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study. Neuroscience 2010, 167:104-110.
18. Kaasinen V., Rinne J.O. Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease. Neurosci. Biobehav. Rev. 2002, 26:785-793.
19. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:593-602.
20. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J. Cereb. Blood Flow Metab. 2000, 20:423-451.
21. Lerer B., Gillon D., Lichtenberg P., Gorfine M., Gelfin Y., Shapira B. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies. Int. Psychogeriatr. 1996, 8:83-102.
22. Matuskey D., Pittman B., Planeta-Wilson B., Walderhaug E., Henry S., Gallezot J.D., et al. Age effects on serotonin receptor 1B as assessed by PET. J. Nucl. Med. 2012, 53:1411-1414.
23. Meltzer C.C., Leal J.P., Mayberg H.S., Wagner H.N., Frost J.J. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J. Comput. Assist. Tomogr. 1990, 14:561-570.
24. Meltzer C.C., Smith G., DeKosky S.T., Pollock B.G., Mathis C.A., Moore R.Y., et al. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 1998, 18:407-430.
25. Murrough J.W., Henry S., Hu J., Gallezot J.D., Planeta-Wilson B., Neumaier J.F., et al. Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder. Psychopharmacology (Berl) 2011, 213:547-553.
26. Nord M., Finnema S.J., Halldin C., Farde L. Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain. Int. J. Neuropsychopharmacol. 2013, 16:1577-1586.
27. Nord M., Finnema S.J., Schain M., Halldin C., Farde L. Test-retest reliability of [(11)C]AZ10419369 binding to 5-HT 1B receptors in human brain. Eur. J. Nucl. Med. Mol. Imaging 2014, 41:301.
28. Pierson M.E., Andersson J., Nyberg S., McCarthy D.J., Finnema S.J., Varnas K., et al. [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain. Neuroimage 2008, 41:1075-1085.
29. Praschak-Rieder N., Willeit M., Wilson A.A., Houle S., Meyer J.H. Seasonal variation in human brain serotonin transporter binding. Arch. Gen. Psychiatry 2008, 65:1072-1078.
30. Roland P.E., Graufelds C.J., Wåhlin J., Ingelman L., Andersson M., Ledberg A., et al. Human brain atlas: for high-resolution functional and anatomical mapping. Hum. Brain Mapp. 1994, 1:173-184.
31. Sari Y. Serotonin1B receptors: from protein to physiological function and behavior. Neurosci. Biobehav. Rev. 2004, 28:565-582.
32. Schain M., Toth M., Cselenyi Z., Stenkrona P., Halldin C., Farde L., et al. Quantification of serotonin transporter availability with [11C]MADAM-a comparison between the ECAT HRRT and HR systems. Neuroimage 2012, 60:800-807.
33. Schain M., Varnäs K., Cselényi Z., Halldin C., Farde L., Varrone A., et al. Evaluation of Two Automated Methods for PET Region of Interest Analysis. Neuroinformatics 2014, (Jun 1, Epub ahead of print).
34. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004, 23(Suppl. 1):S208-S219.
35. Spindelegger C., Stein P., Wadsak W., Fink M., Mitterhauser M., Moser U., et al. Light-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain. World J. Biol. Psychiatry 2012, 13:413-422.
36. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
37. Uchida H., Chow T.W., Mamo D.C., Kapur S., Mulsant B.H., Houle S., et al. Effects of aging on 5-HT(2A) R binding: a HRRT PET study with and without partial volume corrections. Int. J. Geriatr. Psychiatry 2011, 26:1300-1308.
38. Varnas K., Hall H., Bonaventure P., Sedvall G. Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743. Brain Res. 2001, 915:47-57.
39. Varnas K., Nyberg S., Halldin C., Varrone A., Takano A., Karlsson P., et al. Quantitative analysis of [11C]AZ10419369 binding to 5-HT1B receptors in human brain. J. Cereb. Blood Flow Metab. 2011, 31:113-123.
40. Varnas K., Jucaite A., McCarthy D.J., Stenkrona P., Nord M., Halldin C., et al. A PET study with [11C]AZ10419369 to determine brain 5-HT1B receptor occupancy of zolmitriptan in healthy male volunteers. Cephalalgia 2013 (Jul), 33(10):853-860.
41. Varrone A., Sjoholm N., Eriksson L., Gulyas B., Halldin C., Farde L. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur. J. Nucl. Med. Mol. Imaging 2009, 36:1639-1650.
42. Varrone A., Svenningsson P., Forsberg A., Varnas K., Tiger M., Nakao R., et al. Positron emission tomography imaging of 5-hydroxytryptamine receptors in Parkinson's disease. Neurobiol. Aging 2014 (Apr), 35(4):867-875.
43. Wester P., Hardy J.A., Marcusson J., Nyberg P., Winblad B. Serotonin concentrations in normal aging human brains: relation to serotonin receptors. Neurobiol. Aging 1984, 5:199-203.
44. Wong D.F., Wagner H.N., Dannals R.F., Links J.M., Frost J.J., Ravert H.T., et al. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 1984, 226:1393-1396.
45. Woolrich M.W., Jbabdi S., Patenaude B., Chappell M., Makni S., Behrens T., et al. Bayesian analysis of neuroimaging data in FSL. Neuroimage 2009, 45:S173-S186.
46. Yamamoto M., Suhara T., Okubo Y., Ichimiya T., Sudo Y., Inoue M., et al. Age-related decline of serotonin transporters in living human brain of healthy males. Life Sci. 2002, 71:751-757.